European Stroke
OrganisationTenderaMAboyansVESC guidelines on the diagnosis and treatment of peripheral
artery diseases: document covering atherosclerotic disease of extracranial
carotid and vertebral, mesenteric, renal, upper and lower extremity
arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery
Diseases of the European Society of Cardiology (ESC).
Eur Heart J.
2011;32:2851–2906
2.
SchillingerMSabetiSLoeweCBalloon angioplasty versus implantation of nitinol stents in the
superficial femoral artery. N Engl J Med.
2006;354:1879–1888
3.
LairdJRKatzenBTScheinertDNitinol stent implantation versus balloon angioplasty for lesions
in the superficial femoral artery and proximal popliteal artery:
twelve-month results from the RESILIENT randomized trial.
Circ Cardiovasc Interv.
2010;3:267–276
4.
MinarEPokrajacBBudinskyAEndovascular brachytherapy in peripheral
arteries. Vasa.
2003;32:3–9
5.
SchillingerMMinarE.Advances in vascular brachytherapy over the last 10 years: focus
on femoropopliteal applications. J Endovasc
Ther. 2004;11(Suppl
II):II-180–II-191
6.
WaksmanR.Vascular brachytherapy: a landmark chapter in the field of
interventional cardiology.
Eurointervention.
2011;6:669–671
7.
MinarEPokrajacBMacaTEndovascular brachytherapy for prophylaxis of restenosis after
femoropopliteal angioplasty: results of a prospective randomized
study. Circulation.
2000;102:2694–2699
8.
PokrajacBPötterRWolframRMEndovascular brachytherapy prevents restenosis after
femoropopliteal angioplasty: results of the Vienna-3 randomised multicenter
study. Radiother Oncol.
2005;74:3–9
9.
WolframRBudinskyAPokrajacBEndovascular brachytherapy for prophylaxis of restenosis after
femoropopliteal angioplasty: five-year follow-up – prospective
randomized study. Radiology.
2006;240:878–884
10.
MitchellDO'CallaghanAPBoyleEMEndovascular brachytherapy and restenosis following lower limb
angioplasty: systematic review and meta-analysis of randomized clinical
trials. Int J Surg.
2012;10:124–128
11.
PokrajacBKirisitsCSchmidRBeta endovascular brachytherapy using CO2-filled centering
catheter for treatment of recurrent superficial femoropopliteal artery
disease. Cardiovasc Revasc Med.
2009;10:162–165
12.
WernerMScheinertDHennMEndovascular brachytherapy using liquid beta-emitting rhenium-188
for the treatment of long-segment femoropopliteal in-stent
stenosis. J Endovasc Ther.
2012;19:467–475
13.
HöherMWöhrleJWohlfromMIntracoronary beta-irradiation using a rhenium-188 filled balloon
catheter—a randomized trial in patients with de novo and restenotic
lesions. Circulation.
2003;107:3022–3027
14.
LeissnerGWengenmairHSciukJEndovascular brachytherapy (EVBT) with rhenium-188 for restenosis
prophylaxis after angioplasty of infrainguinal lesions: early
experience. Rofo.
2011;183:735–742
15.
DickPSabetiSMlekuschWConventional balloon angioplasty versus peripheral cutting
balloon angioplasty for treatment of femoropopliteal artery in-stent
restenosis: initial experience. Radiology.
2008;248:297–302
16.
LairdJRYeoKK.The treatment of femoropopliteal in-stent
restenosis. J Am Coll Cardiol.
2012;59:24–25
17.
TepeGZellerTAlbrechtTLocal delivery of paclitaxel to inhibit restenosis during
angioplasty of the leg. N Engl J Med.
2008;358:689–699
18.
ZellerTSchmitmeierSTepeGDrugcoated balloons in the lower limb. J
Cardiovasc Surg.
2011;52:235–243
19.
DakeMDScheinertDTepeGZilver PTX Single-Arm Study Investigators. Nitinol stents with
polymer-free paclitaxel coating for lesions in the superficial femoral and
popliteal arteries above the knee: twelve-month safety and effectiveness
results from the Zilver PTX single-arm clinical study.
J Endovasc Ther.
2011;18:613–623
20.
StoneGWEllisSGO'ShaughnessyCDPaclitaxel-eluting stents vs vascular brachytherapy for in-stent
restenosis within bare-metal stents: the TAXUS V ISR randomized
trial. JAMA.
2006;295:1253–1263
21.
HolmesDRTeirsteinPSatlerLSirolimus-eluting stents vs vascular brachytherapy for in-stent
restenosis within bare-metal stents: the SISR randomized
trial. JAMA.
2006;295:1264–1273
22.
Yong-GuangLYan-MeiChLangLDrug-eluting stents vs intracoronary brachytherapy for in-stent
restenosis: a meta-analysis. Clin Cardiol.
2011;34:344–351
